DRIO - רווח תפעולי EBITDA DarioHealth

DarioHealth Corp. (DRIO) is strengthening its position by integrating digital monitoring into corporate insurance plans, which increases switching costs for providers. The company's EBITDA helps track this trend, with the indicator currently standing at 0.00. The business relies on lifelong demand from patients with hypertension and diabetes, generating stable cash flow. An ecosystem of sensors and applications enables user retention and flexible management of subscription pricing.

Professional selection of resilient assets is based on the analysis of actual cash flow from core operations, excluding accounting adjustments. Calculated as net operating income, the recorded EBITDA level confirms the scalability of DarioHealth Corp. (DRIO), where the integration of digital services into insurance plans creates high switching costs for customers and ensures a steady increase in liquid funds.